These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38813766)

  • 21. Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine.
    Green B; Crauwels H; Kakuda TN; Vanveggel S; Brochot A
    Clin Pharmacokinet; 2017 May; 56(5):525-536. PubMed ID: 27665573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
    Skadrić I; Stojković O
    Int J Legal Med; 2020 Mar; 134(2):433-439. PubMed ID: 31858263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose regimens for Chinese adult liver transplant recipients according to the genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in recipients and donors.
    Zhu L; Liao S; Wang N; Ge T; Yang J; Xu G; Wang J; Li K; Li G
    Int J Clin Pharmacol Ther; 2016 Aug; 54(8):587-96. PubMed ID: 27191765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of cytochrome P450 enzyme genetic variants in cannabis hyperemesis syndrome-A case report.
    Kuzin M; Xepapadakos F; Scharrer I; Augsburger M; Eap CB; Schoretsanitis G
    Basic Clin Pharmacol Toxicol; 2021 Jul; 129(1):82-85. PubMed ID: 33740842
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and Caucasian Children Admitted to a Psychiatric Hospital.
    McGrane IR; Loveland JG
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):395-9. PubMed ID: 26871369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population.
    Krasniqi V; Dimovski A; Bytyqi HQ; Eftimov A; Šimičević L; Božina N
    Arh Hig Rada Toksikol; 2017 Sep; 68(3):180-184. PubMed ID: 28976882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of the human cytochrome P450 2C subfamily to the metabolism of and the interactions with endogenous compounds including steroid hormones.
    Niwa T; Yasuda S; Yamamoto Y; Murakami M; Ishii R
    Pharmazie; 2021 Dec; 76(12):611-613. PubMed ID: 34986958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants.
    Hiratsuka M
    Biol Pharm Bull; 2016; 39(11):1748-1759. PubMed ID: 27803446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification.
    Baltzer Houlind M; Hansen L; Iversen E; Rasmussen HB; Larsen JB; Jørgensen S; Dalhoff K; Damkier P; Walls AB; Vermehren C; Andersen TRH; Kallemose T; Christrup L; Westergaard N
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):756-763. PubMed ID: 38403838
    [No Abstract]   [Full Text] [Related]  

  • 30. CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.
    Ortega-Vázquez A; Dorado P; Fricke-Galindo I; Jung-Cook H; Monroy-Jaramillo N; Martínez-Juárez IE; Familiar-López I; Peñas-Lledó E; LLerena A; López-López M
    Pharmacogenomics J; 2016 Jun; 16(3):286-92. PubMed ID: 26122019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4.
    Yoo SE; Yi M; Kim WY; Cho SA; Lee SS; Lee SJ; Shin JG
    Drug Metab Pharmacokinet; 2019 Jun; 34(3):201-208. PubMed ID: 30992242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric assay for genotyping cytochrome p450 2C9 and 2C19: comparison with a microelectronic DNA array.
    Pickering JW; McMillin GA; Gedge F; Hill HR; Lyon E
    Am J Pharmacogenomics; 2004; 4(3):199-207. PubMed ID: 15174901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar substrate specificity of cynomolgus monkey cytochrome P450 2C19 to reported human P450 2C counterpart enzymes by evaluation of 89 drug clearances.
    Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
    Biopharm Drug Dispos; 2015 Dec; 36(9):636-43. PubMed ID: 26348733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenytoin intoxication associated with omeprazole administration in a child with defective CYP2C9.
    Marano M; Nicoletti F; Pro S; Goffredo BM; Cecchetti C; Piervincenzi E; Agolini E; Cocciadiferro D
    Eur J Clin Pharmacol; 2020 May; 76(5):731-732. PubMed ID: 31938857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term fasting alters cytochrome P450-mediated drug metabolism in humans.
    Lammers LA; Achterbergh R; de Vries EM; van Nierop FS; Klümpen HJ; Soeters MR; Boelen A; Romijn JA; Mathôt RA
    Drug Metab Dispos; 2015 Jun; 43(6):819-28. PubMed ID: 25795462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1.
    Powers JL; Buys SS; Fletcher D; Melis R; Johnson-Davis KL; Lyon E; Malmberg EM; McMillin GA
    J Clin Pharmacol; 2016 Dec; 56(12):1570-1581. PubMed ID: 27198207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
    Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
    Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers.
    Chen YR; Yu X; Xu LM; Mei J; Tian ML; Xu M; Jin QY; Ye LB; Yang SX
    Xenobiotica; 2024 Jan; 54(1):38-44. PubMed ID: 38085693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.
    Bahar MA; Setiawan D; Hak E; Wilffert B
    Pharmacogenomics; 2017 May; 18(7):701-739. PubMed ID: 28480783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.